SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-22-000022
Filing Date
2022-02-24
Accepted
2022-02-24 09:03:26
Documents
13
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20220224.htm   iXBRL 8-K 44513
2 EX-99.1 mygn-xyecy21earningsreleas.htm EX-99.1 452699
  Complete submission text file 0000899923-22-000022.txt   665878

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20220224.xsd EX-101.SCH 1884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20220224_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20220224_pre.xml EX-101.PRE 12496
7 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20220224_htm.xml XML 10809
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 22666790
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences